Intravenous iron therapy for patients with iron deficiency and heart failure: a systematic review and meta-analysis of randomized controlled trials
CONCLUSIONS: IV iron therapy holds promise for diminishing HF hospitalizations and enhancing quality of life and 6-minute walk test in HF patients. Yet, its effect on all-cause or cardiovascular mortalities appears limited.PMID:38628339 | PMC:PMC11018061 | DOI:10.1080/08998280.2024.2326387
Source: Baylor University Medical Center Proceedings - Category: Universities & Medical Training Authors: Mohammed Mhanna Michael C Sauer Ahmad Al-Abdouh Ahmad Jabri Azizullah Beran Mahmoud Barbarawi Shareef Mansour Elias B Hanna Source Type: research
More News: Cardiology | Cardiovascular | Heart | Heart Failure | Iron | Universities & Medical Training